Association of initial disease-modifying therapy with later conversion to secondary progressive multiple sclerosis JWL Brown, A Coles, D Horakova, E Havrdova, G Izquierdo, A Prat, ... Jama 321 (2), 175-187, 2019 | 473 | 2019 |
Comparison of the efficacy of azathioprine and rituximab in neuromyelitis optica spectrum disorder: a randomized clinical trial Z Nikoo, S Badihian, V Shaygannejad, N Asgari, F Ashtari Journal of neurology 264, 2003-2009, 2017 | 185 | 2017 |
Towards personalized therapy for multiple sclerosis: prediction of individual treatment response T Kalincik, A Manouchehrinia, L Sobisek, V Jokubaitis, T Spelman, ... Brain 140 (9), 2426-2443, 2017 | 116 | 2017 |
Higher latitude is significantly associated with an earlier age of disease onset in multiple sclerosis C Tao, S Simpson, I Van Der Mei, L Blizzard, E Havrdova, D Horakova, ... Journal of Neurology, Neurosurgery & Psychiatry 87 (12), 1343-1349, 2016 | 98 | 2016 |
COVID-19 among patients with multiple sclerosis: a systematic review M Barzegar, O Mirmosayyeb, M Gajarzadeh, A Afshari-Safavi, N Nehzat, ... Neurology: Neuroimmunology & Neuroinflammation 8 (4), e1001, 2021 | 90 | 2021 |
Comparison of fingolimod, dimethyl fumarate and teriflunomide for multiple sclerosis T Kalincik, EK Havrdova, D Horakova, G Izquierdo, A Prat, M Girard, ... Journal of Neurology, Neurosurgery & Psychiatry 90 (4), 458-468, 2019 | 90 | 2019 |
COVID-19 infection in a patient with multiple sclerosis treated with fingolimod M Barzegar, O Mirmosayyeb, N Nehzat, R Sarrafi, F Khorvash, AH Maghzi, ... Neurology: Neuroimmunology & Neuroinflammation 7 (4), e753, 2020 | 83 | 2020 |
Clinical characteristics and disability progression of early-and late-onset multiple sclerosis compared to adult-onset multiple sclerosis O Mirmosayyeb, S Brand, M Barzegar, A Afshari-Safavi, N Nehzat, ... Journal of clinical medicine 9 (5), 1326, 2020 | 78 | 2020 |
Effect of disease-modifying therapy on disability in relapsing-remitting multiple sclerosis over 15 years T Kalincik, I Diouf, S Sharmin, C Malpas, T Spelman, D Horakova, ... Neurology 96 (5), e783-e797, 2021 | 73 | 2021 |
In patients with multiple sclerosis, both objective and subjective sleep, depression, fatigue, and paresthesia improved after 3 weeks of regular exercise D Sadeghi Bahmani, J Kesselring, M Papadimitriou, J Bansi, U Pühse, ... Frontiers in psychiatry 10, 265, 2019 | 70 | 2019 |
N6‐methyladenosine in RNA and DNA: an epitranscriptomic and epigenetic player implicated in determination of stem cell fate P Ji, X Wang, N Xie, Y Li Stem cells international 2018 (1), 3256524, 2018 | 63 | 2018 |
Can coronavirus disease 2019 (COVID-19) trigger exacerbation of multiple sclerosis? A retrospective study M Barzegar, S Vaheb, O Mirmosayyeb, A Afshari-Safavi, N Nehzat, ... Multiple sclerosis and related disorders 52, 102947, 2021 | 59 | 2021 |
Comparative study of quality of life, anxiety, depression, and fatigue among patients with neuromyelitis optica spectrum disorder and multiple sclerosis: the first report from Iran M Barzegar, S Badihian, O Mirmosayyeb, F Ashtari, M Jamadi, S Emami, ... Multiple sclerosis and related disorders 22, 161-165, 2018 | 57 | 2018 |
A comparison of the effects of reflexology and relaxation on pain in women with multiple sclerosis F Nazari, M Soheili, SM Hosseini, V Shaygannejad Journal of Complementary and Integrative Medicine 13 (1), 65-71, 2016 | 57 | 2016 |
Sexual dysfunction in women with multiple sclerosis: prevalence and impact on quality of life F Nazari, V Shaygannejad, M Mohammadi Sichani, M Mansourian, ... BMC urology 20, 1-10, 2020 | 54 | 2020 |
The Kurtzke EDSS rank stability increases 4 years after the onset of multiple sclerosis: results from the MSBase Registry S Hughes, T Spelman, M Trojano, A Lugaresi, G Izquierdo, ... Journal of Neurology, Neurosurgery & Psychiatry 83 (3), 305-310, 2012 | 51 | 2012 |
Prevalence of multiple sclerosis (MS) in Iran: a systematic review and meta-analysis O Mirmosayyeb, V Shaygannejad, S Bagherieh, AM Hosseinabadi, ... Neurological Sciences 43, 233-241, 2022 | 50 | 2022 |
Prognostic indicators in pediatric clinically isolated syndrome P Iaffaldano, M Simone, G Lucisano, A Ghezzi, G Coniglio, ... Annals of neurology 81 (5), 729-739, 2017 | 48 | 2017 |
BREMSO: a simple score to predict early the natural course of multiple sclerosis R Bergamaschi, C Montomoli, G Mallucci, A Lugaresi, G Izquierdo, ... European journal of neurology 22 (6), 981-989, 2015 | 47 | 2015 |
The value of provocative tests in diagnosis of cervical radiculopathy M Ghasemi, K Golabchi, SA Mousavi, B Asadi, M Rezvani, ... Journal of Research in Medical Sciences: The Official Journal of Isfahan …, 2013 | 47 | 2013 |